Introduction to transcatheter aortic valve implantation.
作者信息
Kleiman Neal
机构信息
Methodist DeBakey Heart & Vascular Center, The Methodist Hospital, Houston, Texas, USA.
出版信息
Methodist Debakey Cardiovasc J. 2012 Apr-Jun;8(2):2-3. doi: 10.14797/mdcj-8-2-2.
Abstract
摘要
相似文献
1
Introduction to transcatheter aortic valve implantation.
Methodist Debakey Cardiovasc J. 2012 Apr-Jun;8(2):2-3. doi: 10.14797/mdcj-8-2-2.
2
Complications at the time of transcatheter aortic valve implantation.
Methodist Debakey Cardiovasc J. 2012 Apr-Jun;8(2):38-41. doi: 10.14797/mdcj-8-2-38.
3
Multimodality noninvasive imaging for transcatheter aortic valve implantation: a primer.
Methodist Debakey Cardiovasc J. 2012 Apr-Jun;8(2):29-37. doi: 10.14797/mdcj-8-2-29.
4
Outcomes of transcatheter and surgical aortic valve replacement in high-risk patients with aortic stenosis and left ventricular dysfunction: results from the Placement of Aortic Transcatheter Valves (PARTNER) trial (cohort A).
Circ Cardiovasc Interv. 2013 Dec;6(6):604-14. doi: 10.1161/CIRCINTERVENTIONS.113.000650. Epub 2013 Nov 12.
5
Vascular closure after transcatheter aortic valve interventions--the current state of play.
J Interv Cardiol. 2012 Oct;25(5):526-32. doi: 10.1111/j.1540-8183.2012.00751.x. Epub 2012 Jun 22.
6
Role of transcatheter aortic valve implantation (TAVI) versus conventional aortic valve replacement in the treatment of aortic valve disease.
Methodist Debakey Cardiovasc J. 2012 Apr-Jun;8(2):4-8. doi: 10.14797/mdcj-8-2-4.
7
Health Status After Transcatheter or Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Increased Surgical Risk: Results From the CoreValve US Pivotal Trial.
JACC Cardiovasc Interv. 2015 Aug 17;8(9):1207-1217. doi: 10.1016/j.jcin.2015.04.018.
8
Clinical studies assessing transcatheter aortic valve replacement.
Methodist Debakey Cardiovasc J. 2012 Apr-Jun;8(2):13-8. doi: 10.14797/mdcj-8-2-13.
9
Transcatheter aortic valve replacement: where will we be in 5 years?
Curr Opin Cardiol. 2011 Mar;26(2):106-12. doi: 10.1097/HCO.0b013e32834398ba.
10
Two-year outcomes after transcatheter or surgical aortic-valve replacement.
N Engl J Med. 2012 May 3;366(18):1686-95. doi: 10.1056/NEJMoa1200384. Epub 2012 Mar 26.
本文引用的文献
1
Transcatheter aortic valve implantation: assessing the learning curve.
JACC Cardiovasc Interv. 2012 Jan;5(1):72-9. doi: 10.1016/j.jcin.2011.09.014. Epub 2011 Dec 21.
2
Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry.
J Am Coll Cardiol. 2011 Nov 8;58(20):2130-8. doi: 10.1016/j.jacc.2011.08.050. Epub 2011 Oct 20.
3
Transcatheter versus surgical aortic-valve replacement in high-risk patients.
N Engl J Med. 2011 Jun 9;364(23):2187-98. doi: 10.1056/NEJMoa1103510. Epub 2011 Jun 5.
4
Clinical Observations on Aortic Stenosis.
Trans Am Clin Climatol Assoc. 1933;49:132-44.
5
Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery.
N Engl J Med. 2010 Oct 21;363(17):1597-607. doi: 10.1056/NEJMoa1008232. Epub 2010 Sep 22.
6
Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation.
Circulation. 2005 Feb 22;111(7):920-5. doi: 10.1161/01.CIR.0000155623.48408.C5. Epub 2005 Feb 14.
7
Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description.
Circulation. 2002 Dec 10;106(24):3006-8. doi: 10.1161/01.cir.0000047200.36165.b8.
8
Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study.
J Am Coll Cardiol. 1997 Mar 1;29(3):630-4. doi: 10.1016/s0735-1097(96)00563-3.
9
Three-year outcome after balloon aortic valvuloplasty. Insights into prognosis of valvular aortic stenosis.
Circulation. 1994 Feb;89(2):642-50. doi: 10.1161/01.cir.89.2.642.
Zotero 插件